Janney Montgomery Scott
GPCR icon

Janney Montgomery Scott’s Structure Therapeutics GPCR Stock Holding History

Janney Montgomery Scott’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Sell
5,364
-1,455
-21% -$64.4K ﹤0.01% 2765
2026
Q1 		$329K Buy
+6,819
New +$467K ﹤0.01% 2321

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Janney Montgomery Scott's GPCR Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Structure Therapeutics (GPCR) stake by 21% in Q2 2026, selling an estimated $64.4K and leaving 5,364 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

Janney Montgomery Scott first reported a position in GPCR in Q1 2026 and has held it in 2 quarters since. The position peaked at $329K in Q1 2026. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Janney Montgomery Scott held 5,364 shares of Structure Therapeutics worth $288K as of Q2 2026.
  • Janney Montgomery Scott sold 1,455 Structure Therapeutics shares in Q2 2026, an estimated $64.4K.
  • Structure Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2765 holding.
  • Janney Montgomery Scott first reported a position in Structure Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Janney Montgomery Scott's Structure Therapeutics position peaked at $329K in Q1 2026.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.